Stockscreener 앱 받기
20.14
136.38%
11.62
시간 외 거래:
19.38
-0.76
-3.77%
Olema Pharmaceuticals Inc 주식(OLMA)의 최신 뉴스
Olema Pharmaceuticals (OLMA) Announces Public Stock Offering, Shares Drop - GuruFocus
Olema Pharmaceuticals (OLMA) Announces Public Offering Plan - GuruFocus
CERAN wrap: Roche phase III BC win seals thesis, boosts Olema - BioWorld MedTech
Olema Pharmaceuticals plans public offering of stock, pre-funded warrants; shares down - MSN
Olema Pharmaceuticals announces plans for public share offering - Investing.com India
Olema Pharmaceuticals stock falls after announcing public offering plans By Investing.com - Investing.com Australia
Olema Pharmaceuticals Plans Public Offering of Common Stock to Support Breast Cancer Therapy Development - Quiver Quantitative
Olema Pharmaceuticals stock falls after announcing public offering plans - Investing.com
Olema Pharmaceuticals Inc terminates ATM prospectus for common stock dated January 6, 2025SEC filing - MarketScreener
Olema Pharmaceuticals Terminates ATM Prospectus - TipRanks
Olema Oncology (Nasdaq: OLMA) Plans Common Stock, Pre-Funded Warrant Offering - Stock Titan
Olema Pharmaceuticals ends at-the-market offering prospectus - Investing.com
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
OLMA: HC Wainwright & Co. Raises Price Target to $36 with a Buy Rating | OLMA Stock News - GuruFocus
Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock - Benzinga
Positive Outlook for Olema’s OPERA-02 Study Following Roche’s Successful Phase 3 Trial Results - TipRanks
JP Morgan Raises Price Target for OLMA to $32.00, Maintains Over - GuruFocus
Olema Pharmaceuticals (OLMA) Surges on Roche's Breast Cancer Tri - GuruFocus
Olema Pharma (OLMA) Stock Rallies Following Competitor Roche’s Cancer Trial Breakthrough - parameter.io
Cancer Focused Olema Pharmaceuticals Stock Soars 150%Here's Why - Benzinga
Olema Pharmaceuticals Stock (OLMA) Opinions on Strategic Collaboration Announcement - Quiver Quantitative
Why Is Olema Pharmaceuticals Stock (OLMA) Up Today? - TipRanks
Roche boosts Olema after breast cancer trial win (RHHBY) - Seeking Alpha
Is Olema Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Olema Pharmaceuticals, Inc. $OLMA Holdings Raised by Persistent Asset Partners Ltd - MarketBeat
How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
Can Olema Pharmaceuticals Inc. stock double in next 5 yearsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Forecasting Olema Pharmaceuticals Inc. price range with options dataJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. reboundWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
News impact scoring models applied to Olema Pharmaceuticals Inc.Portfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6.3%Time to Buy? - MarketBeat
Sector ETF performance correlation with Olema Pharmaceuticals Inc.Trend Reversal & High Conviction Trade Alerts - newser.com
What Wall Street predicts for Olema Pharmaceuticals Inc. stock price - Fundação Cultural do Pará
How to build a dashboard for Olema Pharmaceuticals Inc. stockBreakout Watch & Verified High Yield Trade Plans - newser.com
FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital - MarketBeat
Analysts Set Expectations for OLMA FY2025 Earnings - MarketBeat
Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Update & Stepwise Trade Signal Guides - Fundação Cultural do Pará
Olema Pharmaceuticals Inc. stock momentum explainedTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Optimistic Buy Rating for Olema Pharmaceuticals Driven by Promising Palazestrant Developments - TipRanks
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 7.2% After Earnings Miss - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastPrice Support Zones & High Profit Market Ideas - earlytimes.in
Why Olema Pharmaceuticals Inc. stock could rally in 2025Trade Volume Summary & Safe Entry Zone Tips - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - TipRanks
Optimistic Buy Rating for Olema Pharmaceuticals Driven by Unique Phase III Trials and Promising Market Potential - TipRanks
Will Olema Pharmaceuticals Inc. continue its uptrend2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Olema Oncology (OLMA) Advances Cancer Treatment Trials - GuruFocus
Olema Pharma Q3 net loss widens - MarketScreener
[10-Q] Olema Pharmaceuticals, Inc. Quarterly Earnings Report | OLMA SEC FilingForm 10-Q - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Olema (NASDAQ: OLMA) reports $329M cash, starts OPERA-02 and Pfizer combo study - Stock Titan
Will Olema Pharmaceuticals Inc. stock go up soonTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Has Olema Pharmaceuticals Inc. found a price floorQuarterly Profit Report & AI Powered Market Trend Analysis - newser.com
How geopolitical tensions affect Olema Pharmaceuticals Inc. stock2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
2.08%
0.19%
자본화:
|
볼륨(24시간):